Emergent BioSolutions is a life sciences company focused on providing preparedness and response solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The types of PHTs Co. is addressing are focused on the following five categories: chemical, biological, radiological, nuclear and explosives; emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); and acute, emergency, and community care. Co. operates under three separate business lines: the Government - Medical Countermeasures; the Commercial; and the Services - contract development and manufacturing. The EBS YTD return is shown above.
The YTD Return on the EBS YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether EBS YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the EBS YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|